Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learning

  1. Gehad Youssef
  2. Luke Gammon
  3. Leah Ambler
  4. Sophia Lunetto
  5. Alice Scemama
  6. Hannah Cottom
  7. Kim Piper
  8. Ian C Mackenzie
  9. Michael P Philpott
  10. Adrian Biddle  Is a corresponding author
  1. Queen Mary University of London, United Kingdom
  2. Barts Health NHS Trust, United Kingdom

Abstract

Cancer stem cells (CSCs) undergo epithelial-mesenchymal transition (EMT) to drive metastatic dissemination in experimental cancer models. However, tumour cells undergoing EMT have not been observed disseminating into the tissue surrounding human tumour specimens, leaving the relevance to human cancer uncertain. We have previously identified both EpCAM and CD24 as CSC markers that, alongside the mesenchymal marker Vimentin, identify EMT CSCs in human oral cancer cell lines. This afforded the opportunity to investigate whether the combination of these three markers can identify disseminating EMT CSCs in actual human tumours. Examining disseminating tumour cells in over 12,000 imaging fields from 74 human oral tumours, we see a significant enrichment of EpCAM, CD24 and Vimentin co-stained cells disseminating beyond the tumour body in metastatic specimens. Through training an artificial neural network, these predict metastasis with high accuracy (cross-validated accuracy of 87-89%). In this study, we have observed single disseminating EMT CSCs in human oral cancer specimens, and these are highly predictive of metastatic disease.

Data availability

There are no sequencing datasets associated with this study. Publicly available packages used to analyse immunofluorescent images are listed in the methods section.

The following previously published data sets were used

Article and author information

Author details

  1. Gehad Youssef

    Blizard Institute, Queen Mary University of London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Luke Gammon

    Blizard Institute, Queen Mary University of London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1233-2665
  3. Leah Ambler

    Blizard Institute, Queen Mary University of London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Sophia Lunetto

    Blizard Institute, Queen Mary University of London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Alice Scemama

    Blizard Institute, Queen Mary University of London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Hannah Cottom

    Department of Cellular Pathology, Barts Health NHS Trust, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Kim Piper

    Department of Cellular Pathology, Barts Health NHS Trust, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Ian C Mackenzie

    Blizard Institute, Queen Mary University of London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Michael P Philpott

    Blizard Institute, Queen Mary University of London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1255-4612
  10. Adrian Biddle

    Blizard Institute, Queen Mary University of London, London, United Kingdom
    For correspondence
    a.biddle@qmul.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4371-9720

Funding

Animal Free Research UK

  • Gehad Youssef
  • Michael P Philpott
  • Adrian Biddle

Oracle Cancer Trust

  • Leah Ambler
  • Adrian Biddle

National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/S001573/1)

  • Alice Scemama
  • Adrian Biddle

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Archival human specimens and associated de-identified clinical data was accessed under UK HRA approval with REC ref 18/WM/0326.

Copyright

© 2023, Youssef et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,000
    views
  • 151
    downloads
  • 5
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Gehad Youssef
  2. Luke Gammon
  3. Leah Ambler
  4. Sophia Lunetto
  5. Alice Scemama
  6. Hannah Cottom
  7. Kim Piper
  8. Ian C Mackenzie
  9. Michael P Philpott
  10. Adrian Biddle
(2023)
Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learning
eLife 12:e90298.
https://doi.org/10.7554/eLife.90298

Share this article

https://doi.org/10.7554/eLife.90298

Further reading

    1. Cancer Biology
    Qianqian Ju, Wenjing Sheng ... Cheng Sun
    Research Article

    TAK1 is a serine/threonine protein kinase that is a key regulator in a wide variety of cellular processes. However, the functions and mechanisms involved in cancer metastasis are still not well understood. Here, we found that TAK1 knockdown promoted esophageal squamous cancer carcinoma (ESCC) migration and invasion, whereas TAK1 overexpression resulted in the opposite outcome. These in vitro findings were recapitulated in vivo in a xenograft metastatic mouse model. Mechanistically, co-immunoprecipitation and mass spectrometry demonstrated that TAK1 interacted with phospholipase C epsilon 1 (PLCE1) and phosphorylated PLCE1 at serine 1060 (S1060). Functional studies revealed that phosphorylation at S1060 in PLCE1 resulted in decreased enzyme activity, leading to the repression of phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis. As a result, the degradation products of PIP2 including diacylglycerol (DAG) and inositol IP3 were reduced, which thereby suppressed signal transduction in the axis of PKC/GSK-3β/β-Catenin. Consequently, expression of cancer metastasis-related genes was impeded by TAK1. Overall, our data indicate that TAK1 plays a negative role in ESCC metastasis, which depends on the TAK1-induced phosphorylation of PLCE1 at S1060.

    1. Cancer Biology
    2. Cell Biology
    Rui Hua, Jean X Jiang
    Insight

    Cell crowding causes high-grade breast cancer cells to become more invasive by activating a molecular switch that causes the cells to shrink and spread.